EMA Green-Lights Adapted Vaccines For Use Against COVID-19 Variants, They Will Be Important Ahead Of Winter, Kyriakides Says

10:15 - 02 Σεπτεμβρίου 2022

The European Medicines Agency has given a positive opinion on the use of the first two variant-adapted COVID-19 booster vaccines, produced by BioNTech-Pfizer (Comirnaty) and Moderna (Spikevax) to protect against the Omicron BA.1 subvariant.

newsletter Εγγραφη

Ροη Ειδησεων

ΟΛΕΣ ΟΙ ΕΙΔΗΣΕΙΣ
Altamira22